United States Securities and Exchange Commission · EDGAR Accession 0001787792-25-000009

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-36434
Issuer CIK 1787792
Raising via DEALMAKER SECURITIES LLC

Fisher Wallace Laboratories, Inc.

CorporationDEIncorporated 2019BROOKLYN, NYfisherwallace.com
Progress updateAs of November 5, 2025, Fisher Wallace successfully closed on $228,289.74 of investments from 218 investors
A

The Offering

as disclosed in this filing
Common Stock
$10.96
$50,032
$900,024
October 22, 2025
Expired 235 days ago
$0max $900,024

Target is 6% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Revenue −98% YoYBurn decreasingDebt / assets 996%5 employees
Line itemMost recent FYPrior FYΔ
Revenue47,4122,019,527▼ 98%
Cost of goods sold3,012350,736▼ 99%
Net income(1,579,900)(1,644,382)▲ burn
Total assets154,382361,017▼ 57%
Cash & equivalents41,626311,160▼ 87%
Accounts receivable00
Short-term debt596,720569,243▲ 5%
Long-term debt940,656866,830▲ 9%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36434 · all filings under this campaign
Loading campaign history…